{"organizations": [], "uuid": "c25213b307e2eb1494891b5c9119fa42a2f1e2b1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-cti-biopharma-to-receive-10-mln-mi/brief-cti-biopharma-to-receive-10-mln-milestone-payment-for-trisenox-idUSASB0C1CS", "country": "US", "domain_rank": 408, "title": "BRIEF-CTI BioPharma to receive $10 mln milestone payment for Trisenox", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-18T08:38:00.000+02:00", "replies_count": 0, "uuid": "c25213b307e2eb1494891b5c9119fa42a2f1e2b1"}, "author": "", "url": "https://www.reuters.com/article/brief-cti-biopharma-to-receive-10-mln-mi/brief-cti-biopharma-to-receive-10-mln-milestone-payment-for-trisenox-idUSASB0C1CS", "ord_in_thread": 0, "title": "BRIEF-CTI BioPharma to receive $10 mln milestone payment for Trisenox", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "trisenox", "sentiment": "negative"}, {"name": "cti biopharma", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "teva", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "cti biopharma corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 38 AM / Updated 11 minutes ago BRIEF-CTI BioPharma to receive $10 mln milestone payment for Trisenox Reuters Staff \nJan 18 (Reuters) - Cti Biopharma Corp: \n* CTI BIOPHARMA TO RECEIVE $10 MILLION MILESTONE PAYMENT FOR TRISENOX® \n* CTI BIOPHARMA - ‍TO RECEIVE $10 MILLION MILESTONE PAYMENT FROM TEVA PHARMACEUTICAL INDUSTRIES RELATED TO U.S. FDA APPROVAL OF TRISENOX​ Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-18T08:38:00.000+02:00", "crawled": "2018-01-18T08:53:16.007+02:00", "highlightTitle": ""}